Every asset, protocol, and run. One record.
Manage research assets across teams and organizations, design protocols from what’s already known, and keep a record built for audit.
One search across every library
The same project is found in the author’s, the team’s, and the organization’s libraries, then moves to a partner’s once both sides sign.
Personal library
Found by the author alone, as owner.
PRJ-0011, Transferred
PRJ-0011Spheroid gene-silencing studySearch: gene silencingAccess: OwnerTeam library
Found by the author’s team, as editors.
PRJ-0011, Transferred
PRJ-0011Spheroid gene-silencing studySearch: gene silencingAccess: EditorOrganization library
Found by everyone in the organization, as viewers.
PRJ-0011, Transferred
PRJ-0011Spheroid gene-silencing studySearch: gene silencingAccess: ViewerTransfer
Moves to a partner organization once both sides sign.
Transfer slipPRJ-0011- Signed for The organization
- Signed for The partner
Partner organization
Found by the partner organization, as owner.
PRJ-0011Spheroid gene-silencing studySearch: gene silencingAccess: Owner
From protocol design to experiment-ready
Faithful by default
SymbyAI gives every project a plan that follows the paper.
Signed budgets
SymbyAI starts a run only after someone signs off on its cost.
- Seed and passage the cellsfrom §2.3
- Transfect the siRNA, incubate 48 hfrom §2.4
DeviationIncubated 52 h; the plan says 48 h.
- Extract and quantify the RNAfrom §2.5
- qPCR, three technical replicatesfrom §2.6
Deviations logged
SymbyAI records every departure from the plan as it happens.
Spend against the $2,400 bound
Spent $1,870, $530 under the bound.
RUN-0012Run complete, with one deviation on the record.
What irreproducible results cost
A program built on a published result that doesn’t hold can expend its budget before anyone finds out.
- Amgen
47 of 53 landmark cancer papers failed when Amgen tried to confirm them.
- Bayer
43 of 67 Bayer projects were dropped when the published data didn’t hold up.
- US preclinical research
US$28B a year is spent on US preclinical research that isn’t reproducible.
- Did not hold
One record, four seats
Everyone who has to say yes reads the same record, from their own seat.
The PI
Sees which results the next experiment rests on, and which of them have held.
Claims - Silencing the gene slows cell migration. Contested, P(false) 0.55.
- The siRNA cuts expression by 40%. Upheld, P(false) 0.08. Necessary, confirmed. Supports Silencing the gene slows cell migration.
- The replicates are independent. Contested, P(false) 0.60. Necessary, confirmed. Supports Silencing the gene slows cell migration.
The scientist at the bench
Gets the protocol compiled from the methods, step by step, with what its run may spend.
PROTO-0007Compiled - Sequence
- Sequence: to Seed the cells, transfect the siRNA
- Sequence: to Extract the RNA, run the qPCR
The QA lead
Gets the signed run record: each deviation, the evidence, and who signed off.
RUN-0012Completed - Sequence
- Sequence, travelled: to Extract the RNA, run the qPCR
- Sequence, travelled: to Attest the run record
IT and security
Sets who can see each project and what each member may do, with every change logged.
Access settings - Your organizationPrivate until sharedVisibility
- An owner, two editors, a viewerSet for each projectRoles
- Who changed access, and whenApart from the research recordAudit log
Bring SymbyAI into your lab
SymbyAI keeps your organization’s research assets, protocols, and runs in one record. We’ll go through it with your PIs, QA leads, and IT.
